Literature DB >> 9549784

Potential role for the narcolepsy- and multiple sclerosis-associated HLA allele DQB1*0602 in schizophrenia subtypes.

A Grosskopf, N Müller, A Malo, R Wank.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549784     DOI: 10.1016/s0920-9964(97)00148-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  6 in total

Review 1.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

2.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 3.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

4.  The link between schizophrenia and hypothyroidism: a population-based study.

Authors:  Kassem Sharif; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Arnon D Cohen; Yehuda Shoenfeld; Howard Amital
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

5.  Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis.

Authors:  Y Dauvilliers; C Gaig; L Barateau; F Graus; A Iranzo; R Lopez; J Santamaria
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

6.  Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan.

Authors:  Jia-Yin Yeh; Yu-Chiau Shyu; Sheng-Yu Lee; Shin-Sheng Yuan; Chun-Ju Yang; Kang-Chung Yang; Tung-Liang Lee; Chi-Chin Sun; Liang-Jen Wang
Journal:  Front Psychiatry       Date:  2020-03-25       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.